Dozens of NIH study sections — meetings in which panels of expert scientists consider which research projects the agency should support — have been canceled in recent weeks, after the Trump ...

The National Institutes of Health (NIH) is still blocking most ongoing scientific funding over concerns about “diversity, equity and inclusion” (DEI), according to NIH sources and internal NIH ...

In 1972, testicular cancer was a leading killer of young men — almost uniformly fatal. Today, it has a 90 percent survival rate. The drug responsible for this miraculous reversal, Cisplatin ...

We speak with the Association of American Medical College's Dr. Elena Fuentes-Afflick, discussing the impacts of recent National Institutes of Health funding cuts on public health and medical research ...

The National Institutes of Health (NIH) announced earlier this month it would be cutting billions in costs associated with federally funded research grants that go to various institutions ...

In addition, several medical associations filed a third lawsuit in the same federal court challenging the legality of the NIH Rate Change Notice. The plaintiffs in all three cases offered similar ...

Apparently, this only applies to NIH and not to the indirect costs similarly paid by federal grants from the Department of Defense, the Department of Education, the National Science Foundation ...

As mass layoffs and suspended grant reviews at National Institutes of Health sow more chaos for the nation’s once-cherished scientific enterprise, a federal judge is set to hear arguments Friday ...

About a month after Donald Trump took office as the 47th US president, almost all grant-review meetings remain suspended at the US National Institutes of Health (NIH), preventing the world’s ...

It came from the Department of Health and Human Services, which oversees the NIH, and arrived with clear instructions: Post this announcement on your website immediately. The memo announced a new ...

The CEO of Gaithersburg’s miRecule Inc. was a former oncology researcher with the National Cancer Institute who spun his business out of the NIH in 2016. The company has since secured millions ...

"Dr. Jay Bhattacharya has been a leading voice in support of greater transparency and efficacy in our healthcare bodies, and that's exactly why he is the perfect pick to lead the NIH and help ...